Imara Announces First Patient Dosed in Forte Phase 2b Clinical Trial of IMR-687 in Beta-Thalassemia,

There are currently no approved oral therapies to increase fetal hemoglobin in beta-thalassemia, a rare inherited red blood cell disorder which if left untreated, causes severe anemia, enlarged spleen …, There are currently no approved oral therapies to increase fetal hemoglobin in beta-thalassemia, a rare inherited red blood cell disorder which if left untreated, causes severe anemia, enlarged spleen …, Read More